En Es
Categories

Industry News

PerkinElmer Divests Other Businesses to Focus on Life Sciences and Diagnostics

By Labmedica International staff writers
02 Aug 2022

Image: PerkinElmer is divesting its Applied, Food and Enterprise Services businesses (Photo courtesy of PerkinElmer)

PerkinElmer, Inc. (Waltham, MA; USA) has entered into an agreement with the intention to divest its Applied, Food and Enterprise Services businesses to New Mountain Capital (New York, NY, USA) for total consideration of USD 2.45 billion in cash.


The business being divested includes PerkinElmer’s leading OneSource laboratory and field services, along with a portfolio of atomic spectroscopy, molecular spectroscopy, and chromatography instruments, consumables and reagents that serve the biopharma, food, environmental & safety and applied end markets. The PerkinElmer brand will be transferred with the business, and the transaction is expected to close in the first quarter of 2023, subject to regulatory approvals and other customary closing conditions. The company’s business following the close of the transaction will consist of its Life Sciences and Diagnostics businesses.


“Today's announcement is a pivotal step in the significant portfolio transformation we have been executing on over the last several years," said Prahlad Singh, president and chief executive officer of PerkinElmer. "Following the close of the transaction, we will be a pure-play, high growth, high margin Life Sciences and Diagnostics company with unique scale. The Company’s increased financial strength will support accelerated investment into attractive end markets across science and disease, and drive advanced research, discovery, and improve global health.”


Singh continued, "This milestone has been made possible by the hard work of our nearly 17,000 employees across the globe. It is a validation of our people and the incredible businesses we have built. With this transaction, the Applied, Food and Enterprise Services businesses are gaining a partner who is committed to building on their record of success. Upon closing of the transaction, I believe both organizations will benefit significantly from increased focus and aligned investment on their unique market opportunities.”


Related Links:
PerkinElmer, Inc. 
New Mountain Capital 



E-mail Print
FaceBook Twitter Google+ Linked in

PERKIN ELMER CORPORATION

PerkinElmer provides detection technologies to detect and identify diseases, imaging technologies to help visualize simple to complex diseases, and informatics and software platforms to provide visualization, efficient workflow, data management and analytics. The company’s detection and imaging technologies, laboratory services, and informatics solutions are ideal for scientists, clinicians, and lab professionals.
More info

More articles about PERKIN ELMER CORPORATION

18 May 2021
PerkinElmer to Acquire UK In-Vitro Diagnostics Company Immunodiagnostic Systems
PerkinElmer, Inc. (Waltham, MA; USA) and Immunodiagnostic Systems Holdings PLC (IDS; Boldon, Tyne and Wear, UK) have reached an agreement whereby PerkinElmer will acquire IDS for approximately USD 155 million.
Read More
17 Mar 2021
PerkinElmer’s EUROIMMUN Launches Novel Ultrafast Automated Microscope and Intelligent Software for State-of-the-Art Diagnostics
 EUROIMMUN, a PerkinElmer, Inc. (Waltham, MA; USA) company, has launched the EUROPattern Microscope Live (EPML) compact immunofluorescence microscope, available with the fourth generation of the Company’s well-established EUROLabOffice 4.0 (ELO 4.0) laboratory management software.
Read More
08 Jan 2021
PerkinElmer to Acquire Oxford Immunotec Global PLC
PerkinElmer, Inc. (Waltham, MA; USA) has reached an agreement to acquire Oxford Immunotec Ltd. (Abingdon, UK) that will allow the company to grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection.
Read More

Additional news

27 Sep 2022
Mindray Showcases Hematology Innovations at ISLH 2022
Mindray (Shenzhen, China) showcased its hematology innovations and academic achievements to medical experts from Europe and around the world at the International Symposium on Technological Innovations in Laboratory Hematology (ISLH 2022) held between September 8-10 in Bologna, Italy.
Read More
23 Sep 2022
Parker Labs Partners with Tristel to Deliver Ultrasound Disinfectant for U.S. Market
Parker Laboratories Inc. (Fairfield, NJ, USA) has entered a commercial partnership with Tristel plc (Newmarket, UK) to manufacture and distribute the company's disinfectant foams for U.S. markets.
Read More
19 Sep 2022
Pluslife and FIND Set Collaborate to Empower LMICs with Next-Gen POC Molecular Testing in Women’s Healthcare
Guangzhou Pluslife Biotechnology (Pluslife, Guangzhou, China) and the Foundation for Innovative New Diagnostics (FIND, Geneva, Switzerland) have entered into a strategic collaboration to support low- and middle-income countries (LMICs) in the development of diagnostic tools for women’s healthcare by providing access to next generation point of care (POC) molecular testing technology.
Read More
19 Sep 2022
RSNA 2022 to Showcase Latest Technologies for Advancing Patient Care
The Radiological Society of North America’s (RSNA, Oak Brook, IL, USA) has announced Technical Exhibits highlights for their 108th Scientific Assembly and Annual Meeting (RSNA 2022) held in Chicago at McCormick Place, Nov. 27 – Dec. 1.
Read More
16 Sep 2022
International Hospital Federation Awards 2022 Finalists Announced
The International Hospital Federation (IHF; Geneva, Switzerland) has announced the finalists of the IHF Awards 2022 after scoring entries in seven categories.
Read More
16 Sep 2022
Intelerad Acquires Life Image to Create World’s Largest Medical Image Exchange Network
Intelerad Medical Systems (Raleigh, NC, USA), a leading global provider of enterprise imaging solutions, has acquired Life Image (Newton, MA, USA), one of the largest image exchange networks of curated clinical and imaging data, creating the largest medical image exchange network in the world and laying the groundwork for the elimination of costly CDs as the primary means of image transfer.
Read More
13 Sep 2022
Global Diagnostic Labs Market Driven by Increased POCT Testing and Smart Portable Devices
The global diagnostic labs market is projected grow at a CAGR of 8.3% from over USD 297 billion in 2021 to more than USD 514 billion by 2028, driven by the increasing prevalence of chronic diseases, growing use of POC diagnostics, and rising healthcare expenditures.
Read More
12 Sep 2022
ECR 2023 Now Set to Take Place from 1-5 March in Vienna
The European Society of Radiology (ESR, Vienna, Austria) has announced that the European Congress of Radiology (ECR) 2023 will now take place on March 1-5, 2023 in Vienna.
Read More
09 Sep 2022
Global PCR and Real-Time PCR Testing Market Driven by Need for Early Disease Detection
The global PCR and real time PCR testing market is expected to grow at a CAGR of 6.2% from USD 18.5 billion in 2021 to USD 19.64 billion in 2022 and further grow to USD 24.61 billion in 2026 at a CAGR of 5.8%.
Read More
Copyright © 2000-2022 TradeMed.com. All rights reserved. | Terms And Conditions